Rallybio Corporation

NASDAQ: RLYB · Real-Time Price · USD
0.59
0.04 (8.06%)
At close: Aug 15, 2025, 3:49 PM

Rallybio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.9M 24.49M 56.96M 175.33M
Short-Term Investments
51.61M 85.44M 112.04M n/a
Long-Term Investments
n/a 239K 30K 805K
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
995K 2.05M 10.5M 5.54M
Total Current Assets
67.84M 114.79M 179.5M 180.87M
Property-Plant & Equipment
267K 592K 909K 511K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
267K 831K 939K 1.32M
Total Assets
68.11M 115.62M 180.44M 182.19M
Account Payables
278K 976K 1.11M 603K
Deferred Revenue
848K n/a n/a n/a
Short-Term Debt
154K n/a 181K n/a
Other Current Liabilities
4.96M 3.17M 4.57M 2.99M
Total Current Liabilities
6.24M 9.26M 10.74M 6.55M
Long-Term Debt
n/a n/a 374K n/a
Other Long-Term Liabilities
n/a n/a -374K 32K
Total Long-Term Liabilities
212K 173K 374K 32K
Total Liabilities
6.45M 9.44M 11.12M 6.58M
Total Debt
154K 392K 555K n/a
Common Stock
4K 4K 4K 3K
Retained Earnings
-293.02M -235.25M -160.68M -94.03M
Comprehensive Income
n/a 15K -214K 0.00
Shareholders Equity
61.65M 106.18M 169.32M 175.6M
Total Investments
51.61M 85.67M 112.07M 805K